Market Cap 1.56B
Revenue (ttm) 272.30M
Net Income (ttm) -5.14M
EPS (ttm) N/A
PE Ratio 192.00
Forward PE 133.33
Profit Margin -1.89%
Debt to Equity Ratio 10.30
Volume 1,071,300
Avg Vol 796,686
Day's Range N/A - N/A
Shares Out 37.28M
Stochastic %K 95%
Beta 0.28
Analysts Strong Sell
Price Target $65.57

Company Profile

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops; ILEVRO and NEVANAC, a...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 615 733 4730
Address:
1A Burton Hills Boulevard, Suite 200, Nashville, United States
Finnish_boy
Finnish_boy Jun. 19 at 5:40 AM
$HROW 5 new job posts. Harrow starts to be quite a big house already.
1 · Reply
Finnish_boy
Finnish_boy Jun. 19 at 5:38 AM
$HROW Say hello to $50
0 · Reply
Finnish_boy
Finnish_boy Jun. 19 at 2:38 AM
$HROW It's about to get really nasty for short-sellers. Our time has arrived.🚀💥 next stop $50
0 · Reply
Finnish_boy
Finnish_boy Jun. 18 at 11:03 PM
$HROW My stocks flying. Now recovered fully from huge GOSS loss where i lost $30K. If I had that bet right, i would have now 2X more money. It's was calculated risk. I was totally fine to take that hit. Taking calculated risks in life is sometimes very clever but many people take way too much risk, going all in or something. I never advise to do that. Onwards and upwards. HROW makes ATH this year. That's fair assumption. And $80 is possible. Next year over $100 levels easily. I am now in Prague Czechia. Beer is here 10/10. And super cheap.
1 · Reply
Tennis_4567
Tennis_4567 Jun. 18 at 8:54 PM
$HROW Chart looks awesome
0 · Reply
Finnish_boy
Finnish_boy Jun. 18 at 6:42 PM
$HROW Super
0 · Reply
Taylorstocks
Taylorstocks Jun. 18 at 2:37 PM
$HROW take us into the 50s
0 · Reply
Finnish_boy
Finnish_boy Jun. 18 at 11:43 AM
$HROW Very
0 · Reply
Stacks_Edwards
Stacks_Edwards Jun. 18 at 12:13 AM
$HROW LFG!
0 · Reply
SirBensonbot
SirBensonbot Jun. 17 at 11:03 PM
$HROW long
0 · Reply
Latest News on HROW
Harrow CEO buys $302K, CFO buys $104.7K in common stock

2026-05-15T14:31:15.000Z - 5 weeks ago

Harrow CEO buys $302K, CFO buys $104.7K in common stock


Harrow price target lowered to $60 from $65 at B. Riley

2026-05-14T13:54:22.000Z - 5 weeks ago

Harrow price target lowered to $60 from $65 at B. Riley


Harrow Earnings Call Transcript: Q1 2026

May 12, 2026, 8:00 AM EDT - 5 weeks ago

Harrow Earnings Call Transcript: Q1 2026


Harrow Earnings release: Q1 2026

May 12, 2026, 8:00 AM EDT - 5 weeks ago

Harrow Earnings release: Q1 2026


Harrow Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 5 weeks ago

Harrow Quarterly report: Q1 2026


Harrow Shareholder letter: Q1 2026

May 12, 2026, 8:00 AM EDT - 5 weeks ago

Harrow Shareholder letter: Q1 2026


Harrow Slides: Q1 2026

May 12, 2026, 8:00 AM EDT - 5 weeks ago

Harrow Slides: Q1 2026


Harrow reports Q1 EPS (74c) vs. (50c) last year

2026-05-11T20:41:15.000Z - 5 weeks ago

Harrow reports Q1 EPS (74c) vs. (50c) last year


Harrow Announces First Quarter 2026 Financial Results

May 11, 2026, 4:05 PM EDT - 5 weeks ago

Harrow Announces First Quarter 2026 Financial Results


Harrow Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Harrow Proxy statement: Proxy filing


Harrow Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Harrow Proxy statement: Proxy filing


Harrow announces issuance of J-Code for Iopidine 1%

2026-04-16T11:57:26.000Z - 2 months ago

Harrow announces issuance of J-Code for Iopidine 1%


Harrow Announces the Issuance of J-Code for IOPIDINE® 1%

Apr 16, 2026, 7:00 AM EDT - 2 months ago

Harrow Announces the Issuance of J-Code for IOPIDINE® 1%


Harrow selects LogiCare3PL as distribution partner

2026-04-14T14:35:13.000Z - 2 months ago

Harrow selects LogiCare3PL as distribution partner


LogiCare3PL Selected as Distribution Partner by Harrow

Apr 14, 2026, 10:30 AM EDT - 2 months ago

LogiCare3PL Selected as Distribution Partner by Harrow


Harrow management to meet virtually with BTIG

2026-04-09T20:33:07.000Z - 2 months ago

Harrow management to meet virtually with BTIG


Harrow management to meet virtually with BTIG

2026-04-09T20:25:15.000Z - 2 months ago

Harrow management to meet virtually with BTIG


Harrow price target lowered to $65 from $74 at B. Riley

2026-04-07T13:01:36.000Z - 2 months ago

Harrow price target lowered to $65 from $74 at B. Riley


Harrow price target lowered to $65 from $74 at B. Riley

2026-04-07T12:28:56.000Z - 2 months ago

Harrow price target lowered to $65 from $74 at B. Riley


Harrow Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 8:40 AM EDT - 3 months ago

Harrow Transcript: Leerink Global Healthcare Conference 2026


Harrow Slides: FY 2026

Mar 10, 2026, 8:40 AM EDT - 3 months ago

Harrow Slides: FY 2026


Harrow price target lowered to $60 from $70 at Lake Street

2026-03-04T13:45:34.000Z - 3 months ago

Harrow price target lowered to $60 from $70 at Lake Street


Harrow price target lowered to $62 from $66 at Ladenburg

2026-03-04T12:41:07.000Z - 3 months ago

Harrow price target lowered to $62 from $66 at Ladenburg


Harrow price target raised to $70 from $69 at H.C. Wainwright

2026-03-04T11:12:28.000Z - 3 months ago

Harrow price target raised to $70 from $69 at H.C. Wainwright


Harrow Earnings Call Transcript: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

Harrow Earnings Call Transcript: Q4 2025


Harrow Shareholder letter: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

Harrow Shareholder letter: Q4 2025


Harrow Annual report: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

Harrow Annual report: Q4 2025


Harrow Earnings release: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

Harrow Earnings release: Q4 2025


Harrow Slides: Q4 2025

Mar 3, 2026, 8:00 AM EST - 3 months ago

Harrow Slides: Q4 2025


Harrow sees FY26 revenue $350M-$365M, consensus $386.39M

2026-03-02T21:39:03.000Z - 3 months ago

Harrow sees FY26 revenue $350M-$365M, consensus $386.39M


Harrow reports Q4 EPS 17c vs. 24c last year

2026-03-02T21:26:50.000Z - 3 months ago

Harrow reports Q4 EPS 17c vs. 24c last year


Harrow to Present at Two Investor Conferences in December

Nov 24, 2025, 7:00 AM EST - 7 months ago

Harrow to Present at Two Investor Conferences in December


Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

Nov 18, 2025, 7:00 AM EST - 7 months ago

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals


Harrow Earnings Call Transcript: Q3 2025

Nov 11, 2025, 8:00 AM EST - 7 months ago

Harrow Earnings Call Transcript: Q3 2025


Harrow Quarterly report: Q3 2025

Nov 11, 2025, 8:00 AM EST - 7 months ago

Harrow Quarterly report: Q3 2025


Harrow Earnings release: Q3 2025

Nov 11, 2025, 8:00 AM EST - 7 months ago

Harrow Earnings release: Q3 2025


Harrow Slides: Q3 2025

Nov 11, 2025, 8:00 AM EST - 7 months ago

Harrow Slides: Q3 2025


Harrow Announces Third Quarter 2025 Financial Results

Nov 10, 2025, 4:05 PM EST - 7 months ago

Harrow Announces Third Quarter 2025 Financial Results


ImprimisRx Announces Leadership Changes

Oct 6, 2025, 7:00 AM EDT - 9 months ago

ImprimisRx Announces Leadership Changes


Harrow Transcript: Investor Day 2025

Sep 26, 2025, 11:30 AM EDT - 9 months ago

Harrow Transcript: Investor Day 2025


Harrow Slides: FY 2025

Sep 26, 2025, 11:30 AM EDT - 9 months ago

Harrow Slides: FY 2025


Harrow to Acquire Melt Pharmaceuticals

Sep 26, 2025, 7:00 AM EDT - 9 months ago

Harrow to Acquire Melt Pharmaceuticals


Harrow Launches Harrow Access for All (HAFA)

Sep 25, 2025, 4:05 PM EDT - 9 months ago

Harrow Launches Harrow Access for All (HAFA)


Harrow Announces Agenda and Speakers for Investor & Analyst Day

Sep 15, 2025, 7:00 AM EDT - 9 months ago

Harrow Announces Agenda and Speakers for Investor & Analyst Day


Harrow Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:00 AM EDT - 11 months ago

Harrow Earnings Call Transcript: Q2 2025


Harrow Quarterly report: Q2 2025

Aug 12, 2025, 8:00 AM EDT - 11 months ago

Harrow Quarterly report: Q2 2025


Harrow Earnings release: Q2 2025

Aug 12, 2025, 8:00 AM EDT - 11 months ago

Harrow Earnings release: Q2 2025


Harrow Slides: Q2 2025

Aug 12, 2025, 8:00 AM EDT - 11 months ago

Harrow Slides: Q2 2025


Harrow Announces Second-Quarter 2025 Financial Results

Aug 11, 2025, 4:01 PM EDT - 11 months ago

Harrow Announces Second-Quarter 2025 Financial Results


Harrow Slides: Corporate Presentation

Aug 11, 2025, 7:00 AM EDT - 11 months ago

Harrow Slides: Corporate Presentation


Harrow to Present at Two Investor Conferences in May

May 14, 2025, 7:00 AM EDT - 1 year ago

Harrow to Present at Two Investor Conferences in May


Harrow Earnings Call Transcript: Q1 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Harrow Earnings Call Transcript: Q1 2025


Harrow Quarterly report: Q1 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Harrow Quarterly report: Q1 2025


Harrow Earnings release: Q1 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Harrow Earnings release: Q1 2025


Harrow Slides: Q1 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Harrow Slides: Q1 2025


Harrow Announces First-Quarter 2025 Financial Results

May 8, 2025, 4:01 PM EDT - 1 year ago

Harrow Announces First-Quarter 2025 Financial Results


Harrow Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Harrow Proxy statement: Proxy Filing


Harrow Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Harrow Proxy statement: Proxy Filing


NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC.

Apr 24, 2025, 10:00 AM EDT - 1 year ago

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC.


Harrow Earnings Call Transcript: Q4 2024

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Harrow Earnings Call Transcript: Q4 2024


Harrow Earnings release: Q4 2024

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Harrow Earnings release: Q4 2024


Harrow Annual report: Q4 2024

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Harrow Annual report: Q4 2024


Harrow Slides: Q4 2024

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Harrow Slides: Q4 2024


Harrow Launches VEVYE® Access for All

Mar 17, 2025, 7:00 AM EDT - 1 year ago

Harrow Launches VEVYE® Access for All


Finnish_boy
Finnish_boy Jun. 19 at 5:40 AM
$HROW 5 new job posts. Harrow starts to be quite a big house already.
1 · Reply
Finnish_boy
Finnish_boy Jun. 19 at 5:38 AM
$HROW Say hello to $50
0 · Reply
Finnish_boy
Finnish_boy Jun. 19 at 2:38 AM
$HROW It's about to get really nasty for short-sellers. Our time has arrived.🚀💥 next stop $50
0 · Reply
Finnish_boy
Finnish_boy Jun. 18 at 11:03 PM
$HROW My stocks flying. Now recovered fully from huge GOSS loss where i lost $30K. If I had that bet right, i would have now 2X more money. It's was calculated risk. I was totally fine to take that hit. Taking calculated risks in life is sometimes very clever but many people take way too much risk, going all in or something. I never advise to do that. Onwards and upwards. HROW makes ATH this year. That's fair assumption. And $80 is possible. Next year over $100 levels easily. I am now in Prague Czechia. Beer is here 10/10. And super cheap.
1 · Reply
Tennis_4567
Tennis_4567 Jun. 18 at 8:54 PM
$HROW Chart looks awesome
0 · Reply
Finnish_boy
Finnish_boy Jun. 18 at 6:42 PM
$HROW Super
0 · Reply
Taylorstocks
Taylorstocks Jun. 18 at 2:37 PM
$HROW take us into the 50s
0 · Reply
Finnish_boy
Finnish_boy Jun. 18 at 11:43 AM
$HROW Very
0 · Reply
Stacks_Edwards
Stacks_Edwards Jun. 18 at 12:13 AM
$HROW LFG!
0 · Reply
SirBensonbot
SirBensonbot Jun. 17 at 11:03 PM
$HROW long
0 · Reply
topstockalerts
topstockalerts Jun. 17 at 10:15 PM
$HROW the trend here looks surprisingly solid
0 · Reply
Finnish_boy
Finnish_boy Jun. 17 at 9:41 PM
$HROW 40% gains in a month. Very tasty. Markets work again.
0 · Reply
Stacks_Edwards
Stacks_Edwards Jun. 17 at 8:00 PM
$HROW nice effin close!! Let’s go!! 💪🏻
0 · Reply
flash9875
flash9875 Jun. 17 at 6:26 PM
$HROW short covering is going to drive this for a while...me thinks this runs up to 50 by earnings in Aug.....
0 · Reply
Olivia_Strickland
Olivia_Strickland Jun. 17 at 6:13 PM
$HROW running hot this session, +9% off a clean gap from $38.40 and holding the move. these vertical sessions can stall fast once early buyers start trimming. who's in this one? this is what my scanner flagged: https://tapeboard.com/research/HROW?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=hrow-bk-up-scanner&utm_term=research
0 · Reply
Finnish_boy
Finnish_boy Jun. 17 at 5:29 PM
$HROW Next stop $45
0 · Reply
Finnish_boy
Finnish_boy Jun. 17 at 5:27 PM
$HROW Had to buy more at $42.0 .. you know i set the rules ealier.
1 · Reply
flash9875
flash9875 Jun. 17 at 5:23 PM
$HROW kind of a squeeze type of day
0 · Reply
chrsc
chrsc Jun. 17 at 5:11 PM
$HROW doubles from here.
0 · Reply
Taylorstocks
Taylorstocks Jun. 17 at 4:58 PM
$HROW this has such little resistance upto the 50s
0 · Reply
flash9875
flash9875 Jun. 17 at 1:50 PM
$HROW fin can’t stop buying….
1 · Reply
Rainfield_82
Rainfield_82 Jun. 17 at 1:40 PM
$HROW Above $40
0 · Reply